Metilprednisolona Orion (Methylprednisolone)

Methylprednisolone is a glucocorticoid that modulates inflammatory and immune pathways, making it useful in several clinical settings.

• Inflammatory conditions: alleviates pain, swelling, and redness by suppressing inflammatory mediators.
• Autoimmune diseases: reduces disease activity by dampening aberrant immune responses.
• Allergic reactions: controls severe hypersensitivity symptoms such as bronchospasm and edema.
• Asthma: improves airway function during acute exacerbations by decreasing airway inflammation.
• Rheumatic disorders: limits joint damage and pain in conditions like rheumatoid arthritis.

• Methylprednisolone penetrates cell membranes and binds to intracellular glucocorticoid receptors. The drug‑receptor complex translocates to the nucleus, where it binds glucocorticoid response elements and modulates gene transcription. This up‑regulates anti‑inflammatory proteins (e.g., annexin‑1) and down‑regulates pro‑inflammatory cytokines, chemokines, and adhesion molecules, leading to reduced leukocyte migration and suppressed immune activation. It also influences metabolic pathways, increasing gluconeogenesis and reducing protein synthesis, which contributes to its systemic effects.

Methylprednisolone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Increased appetite or weight gain: patients may notice a rise in hunger and gradual weight increase.
• Mood changes such as irritability or euphoria: emotional swings, anxiety, or heightened sense of well‑being can occur.
• Elevated blood sugar levels: glucose may rise, requiring monitoring especially in diabetic individuals.
• Gastrointestinal discomfort, including nausea or stomach upset: mild abdominal pain, indigestion, or loss of appetite may be reported.

Serious or Rare Side Effects

• Severe infections due to immune suppression: risk of bacterial, viral or fungal infections that can become life‑threatening.
• Osteoporosis or bone fractures with prolonged use: bone density loss may lead to fractures, particularly in the spine or hip.
• Adrenal insufficiency upon abrupt discontinuation: sudden stop can cause cortisol deficiency, leading to fatigue, hypotension, and shock.

When prescribing methylprednisolone, several precautions should be observed to minimize risks and ensure safe use.

• Assess infection risk: evaluate for active or latent infections before initiating therapy.
• Monitor blood glucose: regularly check glucose levels, especially in diabetic patients.
• Evaluate bone health: consider calcium and vitamin D supplementation and periodic bone density testing for long‑term use.
• Taper dosage: avoid abrupt cessation; gradually reduce dose to prevent adrenal crisis.
• Use with caution in pregnancy: limited data; weigh potential benefits against unknown fetal risks.
• Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Methylprednisolone can interact with other medicines, altering its effectiveness or increasing toxicity.

Major Interactions (Avoid)

• CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may raise steroid levels and heighten adverse effects.
• Live vaccines: concurrent use can diminish vaccine efficacy and increase infection risk.
• Anticoagulants (warfarin): corticosteroids may enhance anticoagulant effect, raising bleeding risk.
• Immunosuppressants (e.g., cyclosporine, azathioprine): combined effect can intensify immunosuppression and infection risk.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): combined use can increase gastrointestinal ulceration risk.
• Diuretics (e.g., furosemide): may exacerbate electrolyte disturbances, especially hypokalemia.
• Antidiabetic agents: steroids can raise blood glucose, requiring dose adjustments of insulin or oral hypoglycemics.
• Antihypertensives (e.g., ACE inhibitors): steroids may reduce their antihypertensive effect.
• Antifungal azoles (e.g., fluconazole): may increase steroid plasma concentrations, necessitating monitoring.